ChinaDaily Briefs

Daily Brief China: Greatview Aseptic Packaging, WeRide Corp, Horizon Robotics, New World Development, Eternal Beauty Holdings Limited, Hutchmed China Ltd, China Resources Beverage, Road King Infrastructure, Medco Energi and more

In today’s briefing:

  • GA Pack (468 HK): Stalemate Broken as Management Considers a Possible Counteroffer
  • GAPack (468 HK)’s Co-Founders (Almost) Walk The Walk
  • WeRide Pre-IPO – Peer Comparison – Boasting Partnerships, but Peers Aren’t Too Far Behind
  • Horizon Robotics IPO: High Valuation Is At Risk As NEV Production Forecasts Have Weakened
  • NWD 17 HK Update: De-Leveraging in Process, the Biggest Beneficiary of Fed Rate Cut Cycle
  • Eternal Beauty Pre-IPO Tearsheet
  • Hutchmed China Ltd (13.HK/​​HCM.US) 24H1 – Fruquintinib’s US Sales Beat; Break-Even Is Within Reach
  • China Resources Beverage Pre-IPO – Peer Comparison – Middling
  • Road King – ESG Report – Lucror Analytics
  • Morning Views Asia: Greentown China, Medco Energi, Vedanta Resources


GA Pack (468 HK): Stalemate Broken as Management Considers a Possible Counteroffer

By Arun George

  • Greatview Aseptic Packaging (468 HK) disclosed that Mr Bi Hua Jeff (CEO) and Mr Hong Gang (co-founder) are contemplating a possible voluntary conditional offer. The terms and conditions were not disclosed.
  • Due to the recent AGM protest votes, management needed to provide a credible alternative to shareholders to ensure that Shandong Xinjufeng Technology Packaging (301296 CH)’s offer failed.   
  • Shandong Xinjufeng’s likely game plan is to wait for a binding counteroffer, focus on satisfying the preconditions, and requisition an EGM again to get Board representation.

GAPack (468 HK)’s Co-Founders (Almost) Walk The Walk

By David Blennerhassett

  • To say Greatview Aseptic Packaging (468 HK)‘s management and Shandong Xinjufeng (301296 CH) (XJF) don’t get along is an understatement. GAPack has labelled XJF’s pre-conditional Offer hostile and unwelcome.
  • Last night (6th August), co-founders Jeff Bi and Gang Hong tabled a non-binding Offer. No price was mentioned. Collectively they hold 14.72% of shares out compared to XJF’s 26.8%.
  • A firm Offer (and price) would have been welcome, and this probably reflects on-going funding negotiations. But the announcement will give minorities pause if/when tendering into XJF’s Offer.

WeRide Pre-IPO – Peer Comparison – Boasting Partnerships, but Peers Aren’t Too Far Behind

By Clarence Chu

  • WeRide Corp (WER CH) is looking to raise around US$300m in its upcoming US IPO.
  • WeRide provides autonomous driving products and services from L2 to L4 of driving automation.
  • We had looked at the firm’s past performance in an earlier note. In this note, we will undertake a peer comparison.

Horizon Robotics IPO: High Valuation Is At Risk As NEV Production Forecasts Have Weakened

By Andrei Zakharov

  • Horizon Robotics, a leading provider of ADAS and AD solutions for passenger vehicles, plans to raise up to $500M in Hong Kong IPO.
  • I expect Horizon Robotics will price its IPO below last round valuation of ~$8.7B as revenue growth will slow below 50% y/y in 2024, down from 71% y/y in 2023.
  • The company’s key competitors, including Mobileye and Microchip Technology, revised their revenue guidance downwards for the second half of 2024.

NWD 17 HK Update: De-Leveraging in Process, the Biggest Beneficiary of Fed Rate Cut Cycle

By Jacob Cheng

  • In this update, we analyzed recent NWD’s corporate actions, which show their de-leveraging plan is on track
  • NWD, having the highest gearing among HK RE names, will become the biggest beneficiary if Fed starts a new rate cut cycle
  • Valuation is compelling.  There is ample upside assuming a bear case scenario.  It is a BUY

Eternal Beauty Pre-IPO Tearsheet

By Akshat Shah

  • Eternal Beauty Holdings Limited (EBHL12 HK) is looking to raise about US$200m in its upcoming Hong Kong IPO. The deal will be run by BNP Paribas, Citic, CMBI and DBS.
  • Eternal Beauty is the largest brand management company of perfumes in the combined markets of Mainland China, Hong Kong and Macau, in terms of retail sales in 2023.
  • The company has a diverse portfolio of iconic brands of not only perfumes, but also color cosmetics, skincare products, personal care products, eyewear and home fragrances under management.

Hutchmed China Ltd (13.HK/​​HCM.US) 24H1 – Fruquintinib’s US Sales Beat; Break-Even Is Within Reach

By Xinyao (Criss) Wang

  • Fruquintinib US sales continue to be the main performance driver. License-out expectations for surufatinib is low.Highlight for savolitinib is the combination with osimertinib for NSCLC, which would bring high growth.
  • Future playbook of HUTCHMED is “continued sharp reduction of expenses + milestones from Takeda based on fruquintinib overseas sales = rapid narrowng of losses”.2024 overseas market sales may exceed US$300m.
  • There is not much problem with HUTCHMED completing its performance guidance for the year 2024. Reasonable market value range for HUTCHMED is US$1.75-3.75 billion. Breakeven is expected in 2025.

China Resources Beverage Pre-IPO – Peer Comparison – Middling

By Sumeet Singh

  • China Resources Beverage is looking to raise US$1bn in its upcoming Hong Kong IPO.
  • China Resources Beverage manufactures and sells packaged drinking water and RTD soft beverages in China.
  • In our earlier note, we talked about the company’s past performance. In this note, we will undertake a peer comparison.

Road King – ESG Report – Lucror Analytics

By Leonard Law, CFA

Lucror Analytics’ ESG Scores are based on a 3-tiered scale and are adjusted for Controversies (if applicable).
We assess Road King’s ESG as “Adequate”, in line with the Environmental, Social and Governance scores. Controversies are “Immaterial” and Disclosure is “Adequate”.


Morning Views Asia: Greentown China, Medco Energi, Vedanta Resources

By Leonard Law, CFA

Lucror Analytics Morning Views comprise our fundamental credit analysis, opinions and trade recommendations on high yield issuers in the region, based on key company-specific developments in the past 24 hours. Our Morning Views include a section with a brief market commentary, key market indicators and a macroeconomic and corporate event calendar.


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars